1.Suggestions for the diagnostic criteria of alcoholic hepatopathy.
Chinese Journal of Hepatology 2002;10(2):141-141
Alanine Transaminase
;
blood
;
Aspartate Aminotransferases
;
blood
;
Female
;
Humans
;
Liver
;
pathology
;
Liver Diseases, Alcoholic
;
blood
;
diagnosis
;
Male
;
gamma-Glutamyltransferase
;
blood
2.Serum prohepcidin levels in chronic hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease.
Sang Hyub LEE ; Sook Hyang JEONG ; Young Soo PARK ; Jin Hyeok HWANG ; Jin Wook KIM ; Nayoung KIM ; Dong Ho LEE
The Korean Journal of Hepatology 2010;16(3):288-294
BACKGROUND/AIMS: Patients with various chronic liver diseases frequently have increased body iron stores. Prohepcidin is an easily measurable precursor of hepcidin, which is a key regulator of iron homeostasis. This study investigated the serum prohepcidin levels in patients with various chronic liver diseases with various etiologies. METHODS: Serum prohepcidin levels were measured in patients with chronic hepatitis C (CH-C) (n=28), nonalcoholic fatty liver disease (NAFLD) (n=24), and alcoholic liver disease (ALD) (n=22), and in healthy controls (n=25) using commercial ELISA. Serum interleukin 6 (IL-6) levels and blood iron indices were also measured. RESULTS: The serum levels of both prohepcidin and IL-6 were significantly higher in CH-C patients than in healthy controls, and there was a positive correlation between the IL-6 and prohepcidin levels (r=0.505, p=0.020). The prohepcidin levels in ALD patients did not differ from those in controls, despite their significantly elevated IL-6 levels. There was a tendency for a negative correlation between serum prohepcidin levels and transferrin saturation in ALD patients (r=-0.420, p=0.051). Neither prohepcidin nor IL-6 was significantly elevated in the NAFLD group, despite the presence of elevated serum iron and ferritin levels. CONCLUSIONS: The role of prohepcidin may differ in different human liver diseases. In the setting of CH-C, both the serum prohepcidin and IL-6 levels were significantly elevated and were positively correlated with each other.
Adult
;
Aged
;
Antimicrobial Cationic Peptides/*blood/physiology
;
Fatty Liver/blood/diagnosis
;
Female
;
Ferritins/blood
;
Hepatitis C, Chronic/*blood/diagnosis
;
Humans
;
Interleukin-6/blood
;
Iron/blood
;
Liver Diseases, Alcoholic/*blood/diagnosis
;
Male
;
Middle Aged
;
Protein Precur
3.The prevalence of diabetes mellitus in chronic liver disease.
Hyun Chul LEE ; Kap Bum HUH ; Sung Kwan HONG ; Hyun Jung ROH ; Byung Joo CHOI ; Sang Hoon AN ; Il SUH ; Kwang Hyup HAN
Korean Journal of Medicine 1999;57(3):281-287
The insulin resistance and the altered glucose metabolism in chronic liver disease increase the alteration of glucose intolerance and the prevalence of diabetes mellitus. The prevalence of DM is higher in advanced cirrhosis than in early cirrhosis and higher in C-viral hepatitis or alcoholic liver disease than in B-viral hepatitis. The purpose of this study is to assess the prevalence of DM in chronic liver disease in Korea. METHODS: We reviewed the medical records of 417 patients with chronic liver disease who visit the Yonsei University Sevrance Hospital from January 1994 to March 1998. We examined fasting blood sugar, biochemical study and abdominal ultrasonography. DM was defined on the basis of fasting hyperglycemia (fasting blood sugar exceeding 140 mg/dl) at least two consecutive samples or active treatment with insulin or oral hypoglycemic agents. RESULTS:1) The DM prevalence was 16.8%(70 cases) in total patients and 25.0% (56 cases) in cirrhotic patients. 2) According to sex, there was no statistically significant difference in DM prevalence(16.8% in men and 18.1% in women P=0.78). 3) The DM prevalence was increased with increasing of age(0% in below 30 years, 4.9% in 31-40, 19.6% in 41-50, 22.9% in 51-60, 21.3% in 61-70 and 44.4% in over 71 years, p<0.01). 3) According to severity of liver disease, the DM prevalence was higher in uncompensated cirrhosis than in compensated cirrhosis(2.3% in chronic viral carrier, 8.8% in chronic hepatitis, 17.9% in cirrhosis Child class A, 33.9% in class B, 29.5% in class C). 4) According to cause of liver disease, the DM prevalence was higher in C-viral hepatitis and alcoholics than in B-viral hepatitis(12.1% in B-viral hepatitis, 35.1% in C-viral hepatitis, 40.0% in alcoholics). CONCLUSION: The prevalence of diabetes in the patients with chronic liver disease is much higher than in general population. And the DM prevalence is increased in advanced cirrhosis and C-viral or alcoholic hepatitis. The early diagnosis and treatment of DM in chronic liver disease patients are important.
Alcoholics
;
Blood Glucose
;
Child
;
Diabetes Mellitus*
;
Early Diagnosis
;
Fasting
;
Female
;
Fibrosis
;
Glucose
;
Glucose Intolerance
;
Hepatitis
;
Hepatitis, Alcoholic
;
Hepatitis, Chronic
;
Humans
;
Hyperglycemia
;
Hypoglycemic Agents
;
Insulin
;
Insulin Resistance
;
Korea
;
Liver Diseases*
;
Liver Diseases, Alcoholic
;
Liver*
;
Male
;
Medical Records
;
Metabolism
;
Prevalence*
;
Ultrasonography
4.The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma.
Keunhee KANG ; Ji Hoon KIM ; Seong Hee KANG ; Beom Jae LEE ; Yeon Seok SEO ; Hyung Joon YIM ; Jong Eun YEON ; Jong Jae PARK ; Jae Seon KIM ; Young Tae BAK ; Kwan Soo BYUN
Gut and Liver 2015;9(2):224-230
BACKGROUND/AIMS: Prothrombin induced by vitamin K deficiency or antagonist II (PIVKA-II) is a widely used diagnostic marker for hepatocellular carcinoma (HCC). We evaluated the correlation between alcoholic liver disease (ALD) and serum PIVKA-II levels in chronic liver disease (CLD) patients. METHODS: We retrospectively reviewed the medical records of 2,528 CLD patients without HCC. Among these patients, 76 exhibited serum high PIVKA-II levels of >125 mAU/mL (group 1). We categorized 76 control patients matched by age, sex, and the presence of liver cirrhosis from the remaining patients who were negative for serum PIVKA-II (group 2). RESULTS: Group 1 revealed increased antibiotic usage (23.7% vs 2.6%, p<0.001) and incidence of ALD (60.5% vs 14.5%, p<0.001) as well as elevated aspartate aminotransferase (52.5 IU/L vs 30.5 IU/L, p=0.025) and gamma glutamyl transpeptidase (67.5 IU/L vs 36.5 IU/L, p=0.005) levels compared with group 2. Further, group 1 was significantly associated with a worse Child-Pugh class than group 2. In the multivariate analysis, ALD (odds ratio [OR], 7.151; p<0.001) and antibiotic usage (OR, 5.846; p<0.001) were significantly associated with positive PIVKA-II levels. CONCLUSIONS: Our study suggests that ALD and antibiotics usage may be confounding factors when interpreting high serum PIVKA-II levels in patients without HCC. Therefore, serum PIVKA-II levels in patients with ALD or in patients administered antibiotics should be interpreted with caution.
Adult
;
Age Distribution
;
Aged
;
Anti-Bacterial Agents/therapeutic use
;
Aspartate Aminotransferases/blood
;
Biomarkers/*blood
;
Carcinoma, Hepatocellular/blood
;
Diagnosis, Differential
;
Female
;
Humans
;
Liver Cirrhosis/blood
;
Liver Diseases, Alcoholic/*blood
;
Liver Neoplasms/blood
;
Male
;
Matched-Pair Analysis
;
Middle Aged
;
Multivariate Analysis
;
Protein Precursors/*blood
;
Prothrombin/analysis
;
Retrospective Studies
;
Sex Distribution
;
gamma-Glutamyltransferase/blood
5.The Influence of Alcoholic Liver Disease on Serum PIVKA-II Levels in Patients without Hepatocellular Carcinoma.
Keunhee KANG ; Ji Hoon KIM ; Seong Hee KANG ; Beom Jae LEE ; Yeon Seok SEO ; Hyung Joon YIM ; Jong Eun YEON ; Jong Jae PARK ; Jae Seon KIM ; Young Tae BAK ; Kwan Soo BYUN
Gut and Liver 2015;9(2):224-230
BACKGROUND/AIMS: Prothrombin induced by vitamin K deficiency or antagonist II (PIVKA-II) is a widely used diagnostic marker for hepatocellular carcinoma (HCC). We evaluated the correlation between alcoholic liver disease (ALD) and serum PIVKA-II levels in chronic liver disease (CLD) patients. METHODS: We retrospectively reviewed the medical records of 2,528 CLD patients without HCC. Among these patients, 76 exhibited serum high PIVKA-II levels of >125 mAU/mL (group 1). We categorized 76 control patients matched by age, sex, and the presence of liver cirrhosis from the remaining patients who were negative for serum PIVKA-II (group 2). RESULTS: Group 1 revealed increased antibiotic usage (23.7% vs 2.6%, p<0.001) and incidence of ALD (60.5% vs 14.5%, p<0.001) as well as elevated aspartate aminotransferase (52.5 IU/L vs 30.5 IU/L, p=0.025) and gamma glutamyl transpeptidase (67.5 IU/L vs 36.5 IU/L, p=0.005) levels compared with group 2. Further, group 1 was significantly associated with a worse Child-Pugh class than group 2. In the multivariate analysis, ALD (odds ratio [OR], 7.151; p<0.001) and antibiotic usage (OR, 5.846; p<0.001) were significantly associated with positive PIVKA-II levels. CONCLUSIONS: Our study suggests that ALD and antibiotics usage may be confounding factors when interpreting high serum PIVKA-II levels in patients without HCC. Therefore, serum PIVKA-II levels in patients with ALD or in patients administered antibiotics should be interpreted with caution.
Adult
;
Age Distribution
;
Aged
;
Anti-Bacterial Agents/therapeutic use
;
Aspartate Aminotransferases/blood
;
Biomarkers/*blood
;
Carcinoma, Hepatocellular/blood
;
Diagnosis, Differential
;
Female
;
Humans
;
Liver Cirrhosis/blood
;
Liver Diseases, Alcoholic/*blood
;
Liver Neoplasms/blood
;
Male
;
Matched-Pair Analysis
;
Middle Aged
;
Multivariate Analysis
;
Protein Precursors/*blood
;
Prothrombin/analysis
;
Retrospective Studies
;
Sex Distribution
;
gamma-Glutamyltransferase/blood
6.Acute Hepatic Encephalopathy Presenting as Cortical Laminar Necrosis: Case Report.
Jong Mun CHOI ; Yoon Hee KIM ; Sook Young ROH
Korean Journal of Radiology 2013;14(2):324-328
We report on a 55-year-old man with alcoholic liver cirrhosis who presented with status epilepticus. Laboratory analysis showed markedly elevated blood ammonia. Brain magnetic resonance imaging (MRI) showed widespread cortical signal changes with restricted diffusion, involving both temporo-fronto-parietal cortex, while the perirolandic regions and occipital cortex were uniquely spared. A follow-up brain MRI demonstrated diffuse cortical atrophy with increased signals on T1-weighted images in both the basal ganglia and temporal lobe cortex, representing cortical laminar necrosis. We suggest that the brain lesions, in our case, represent a consequence of toxic effect of ammonia.
Ammonia/blood
;
Atrophy/pathology
;
Brain Diseases/blood/*diagnosis/*etiology
;
Hepatic Encephalopathy/*complications
;
Humans
;
Liver Cirrhosis, Alcoholic/*complications
;
Magnetic Resonance Imaging/*methods
;
Male
;
Middle Aged
;
Necrosis/pathology
;
Status Epilepticus/pathology
7.Clinical Characteristics and Prognostic Impact of Bacterial Infection in Hospitalized Patients with Alcoholic Liver Disease.
Jin Kyoung PARK ; Chang Hun LEE ; In Hee KIM ; Seon Min KIM ; Ji Won JANG ; Seong Hun KIM ; Sang Wook KIM ; Seung Ok LEE ; Soo Teik LEE ; Dae Ghon KIM
Journal of Korean Medical Science 2015;30(5):598-605
Bacterial infection is an important cause of death in patients with liver cirrhosis. The aim of this study was to investigate the clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease (ALD). We retrospectively analyzed data from 409 patients consecutively admitted to a tertiary referral center with ALD diagnosis. Of a total of 544 admissions, 133 (24.4%) cases presented with bacterial infection, of which 116 were community-acquired whereas 17 were hospital-acquired. The common types of infection were pneumonia (38%), biliary tract infection (17%), soft tissue infection (12%), and spontaneous bacterial peritonitis (9%). Diabetes, serum Na <135 mM/L, albumin <2.5 g/dL, C-reactive protein > or =20 mg/L, systemic inflammatory response syndrome (SIRS) positivity were independently associated with bacterial infection in patients with ALD. Overall 30-day and 90-day mortalities in patients with bacterial infection were significantly (P < 0.001) higher than those without infection (22.3% vs. 5.1% and 32.3% vs. 8.2%, respectively). Furthermore, bacterial infection (HR, 2.2; 95% CI, 1.049-4.579, P = 0.037), SIRS positivity (HR, 2.5; 95% CI, 1.240-4.861, P = 0.010), Maddrey's discriminant function score > or =32 (HR, 2.3; 95% CI, 1.036-5.222, P = 0.041), and hemoglobin <12 g/dL (HR, 2.4; 95% CI, 1.081-5.450, P = 0.032) were independent predictors of short-term mortality. In conclusion, bacterial infection and SIRS positivity predicted short-term prognosis in hospitalized patients with ALD. A thorough evaluation at admission or on clinical deterioration is required to detect possible infection with prompt management.
Adult
;
Aged
;
Bacterial Infections/complications/*diagnosis/mortality
;
C-Reactive Protein/analysis
;
Candida/isolation & purification
;
Female
;
Gram-Negative Bacteria/isolation & purification
;
Gram-Positive Bacteria/isolation & purification
;
Hemoglobins/analysis
;
Hospitalization
;
Humans
;
Linear Models
;
Liver Diseases, Alcoholic/complications/*diagnosis
;
Male
;
Middle Aged
;
Patients
;
Prognosis
;
Proportional Hazards Models
;
Retrospective Studies
;
Risk Factors
;
Serum Albumin/analysis
;
Sodium/blood
;
Survival Analysis
;
Systemic Inflammatory Response Syndrome/complications/diagnosis
;
Tertiary Care Centers